HSS News Network

Media Relations/Public Relations Contact Information

To learn more about ongoing news stories at Hospital for Special Surgery, please contact our Public Relations Department.

Press Releases | view all

• Tissue Damage from Metal-on-Metal Hip Implants Appears Before Pain Symptoms Appear
  May 15, 2013 - Metal-on-metal hip implants can cause inflammation of the joint lining (synovitis) long before symptoms appear, and magnetic resonance imaging (MRI) can be used to identify this inflammation, according to a new study by researchers at Hospital for Special Surgery....
  
  
• Hospital for Special Surgery Launches Major Long Island Expansion
  May 15, 2013 - Hospital for Special Surgery (HSS) has major plans for Long Island. A significant expansion of HSS Long Island in Uniondale has just been completed....
  
  
• 150th Anniversary Symposium Tackles Health Care Issues and Highlights Research Advances That Will Transform Medicine
  May 8, 2013 - Beginning with a trip back in time to Civil War medicine, to the pressing challenges facing U.S. health care today, world-renowned thought leaders offered innovative solutions for an era of health-care reform at a symposium marking the 150th anniversary of Hospital for Special Surgery....
  
  

HSS in the News | view all

• MRI Predicts Failing MoM Hip Implants
  May 17, 2013—MedPage Today
  In an interview with MedPage Today, Dr. Hollis Potter said MRI analysis of synovial fluid is highly predictive of abnormal synovial response, unlike serum ion testing, radiographic analysis or even patient symptoms...
  
  
• GE Healthcare unveils technology for imaging metal implants
  May 16, 2013—DOTmed Daily News
  Any patient with metal implants can now receive a clear, readable MRI scan thanks to new technology from GE Healthcare. The company unveiled its new software, MAVRIC SL, at Hospital for Special Surgery...
  
  
• Bisphosphonates May Reduce Heart Attack Risk in RA Patients
  May 10, 2013—Arthritis Today
  A new study published in the May issue of Journal of Bone and Mineral Research (JBMR) found that use of bisphosphonates – bone-building drugs – appear to significantly lower the risk of heart attacks in rheumatoid arthritis (RA) patients....